Community News - Archive

December 2018

• Toni M. Kutchan, PhD, and Megan Augustin, of Donald Danforth Plant Science Center contribute Cheilanthifoline Synthase (CYP719A14), Salutaridine Synthase (CYP719B1), and Stylopine Synthase (CYP719A13).
• University of Cambridge joins the Kerafast Community.
• Food and Drug Administration joins the Kerafast Community.
• University of Colorado Denver joins the Kerafast Community.
• A*STAR Institute of Molecular and Cell Biology (IMCB) Monoclonal Antibody Unit contributes Chikungunya virus, Hepatitis C, Influenza A, MERS, RNA pol R2, SARS, and Zebrafish Mind Bomb Antibodies.
• Brian Burke, PhD, of A*STAR Institute of Medical Biology (IMB) contributes Anti-Laminin Antibodies.

November 2018

• Department of Veterans Affairs joins the Kerafast Community.
• Northern Arizona University joins the Kerafast Community.
• University of Cologne joins the Kerafast Community.
• Jochen Walter, PhD and Michael T. Heneka, PhD, of University of Bonn contribute Amyloid-beta [7H3D6] Antibody, phospho Amyloid-beta, Ser8 [1E4E11] Antibody, phospho Amyloid-beta, Ser26 [5H11C10] Antibody, and nitrated Amyloid Beta, Tyr10 [3-NTyr10-Ab] Antibody.
• Dorothee Herlyn, DVM, of The Wistar Institute contributes Anti-GD2 Idiotypic Antibodies.
• Jeffrey A. Yoder, PhD, of North Carolina State University contributes Zebrafish Novel Immune-Type Receptor 9 (Nitr9) Antibodies.

October 2018

• Philip Lazarus, PhD, of Washington State University contributes Cytochrome (CYP) 450 Expressing HEK293 Cell Lines.
• Blaine A. Pfeifer, PhD, of Tufts University contributes Erythromycin A Production Plasmids.
• Anna Marie Pyle, PhD, of Yale University contributes MarathonRT Reverse Transcriptase.
• Donghoon Chung, PhD, of University of Louisville contributes ZVEEV nsP2 [8A4B3] Antibody.

September 2018

• Washington University in Saint Louis joins the Kerafast Community.
• Christopher J. Ehrhardt, PhD, of Virginia Commonwealth University contributes Multispectral Cell Imaging Analysis Service.
• Akhil B. Vaidya, PhD, of Drexel University contributes pHHyDHOD-GFP Expression Plasmid.
• David M. Bader, PhD, of Vanderbilt University contributes Centromere Protein F (CENP-F) Antibodies.
• Maolin Guo, PhD, of University of Massachusetts Dartmouth contributes Reversible Fluorescent Fe3+ Sensor (RPE).

August 2018

• Ned A. Porter, PhD and Keri A. Tallman, PhD, of Vanderbilt University contribute ¹³C₆-UV-Biotin-azide.
• Javier Gordon Ogembo, PhD, of City of Hope contributes EBV gp350 [HB5] Antibody.
• University of Bonn joins the Kerafast Community.
• Henryk F. Urbanski, PhD, DSc, of Oregon Health & Science University contributes GnRH Antibodies.
• Nianli Sang, PhD, of Drexel University contributes pcDNA3-Gal4-HIF-1a Plasmids, pcDNA3-DBD Plasmid, and pM-Gal4-HIF-1a Plasmid.

July 2018

• University of California, Santa Cruz joins the Kerafast Community.
• Matthew I. Gibson, PhD, of University of Warwick contributes Fmoc 4-azido-L-phenylalanine.
• University of Kentucky joins the Kerafast Community.
• Blaine A. Pfeifer, PhD, of University at Buffalo and Chaitan Khosla, PhD, of Stanford University contribute 6dEB plasmids and BAP1 E. coli Strain.
• David L. Blum, PhD and Michelle M. Lewis, PhD, of University of Georgia contribute Recombinant TEV Protease.
• Andrzej T. Slominski, MD, PhD, of University of Alabama at Birmingham contributes Hamster Melanoma Cell Line (AbC1).
• Jaime F. Modiano, VMD, PhD, of University Minnesota, Twin Cities contributes additional Canine Cancer Cell Lines.

June 2018

• Michael W. Riggs, DVM, PhD, of University of Arizona contributes GP25-200/P23 Antibodies.
• University of Hawaiʻi joins the Kerafast Community.
• Agency for Science, Technology and Research (A*STAR) joins the Kerafast Community.
• Toni M. Kutchan, PhD, and Megan Augustin, of Donald Danforth Plant Science Center contribute Morphinan N-demethylase (MND).
• Andre Veillette, MD, of Montreal Clinical Research Institute contributes Fyn and Lck Antibodies.
• South Dakota State University joins the Kerafast Community.
• Sylvain Canesi, PhD, of University of Quebec at Montreal contributes 1,2-Dimyristoyl-sn-glycero-3-phosphoethanol-ferroceneacetamide (FC-DSP).
• Jihong Bai, PhD, of Fred Hutchinson Cancer Research Center contributes SUMO Smt3p, SUMO4, mini SOG, TIAM1, and TagRFP Antibodies.
• University of Warwick joins the Kerafast Community.
• Now available: Human Monocyte Derived Dendritic Cells.

May 2018

• Kazuko Nishikura, PhD, of The Wistar Institute contributes Tudor-SN and ADAR-1, -2, and -3 Antibodies.
• Oregon Health & Science University joins the Kerafast Community.
• James M. Termini, PhD, of University of Miami contributes O-linked Glycosylation Knock Out Cell Lines.
• Jane R. Parnes, MD and Susan Prohaska, PhD, of Stanford University contribute CD6 [34-3] Antibody.
• Stacia A. Sower, PhD, of University of New Hampshire contributes Guinea pig GnRH [TF60] Antibody and Peptides.
• University of Alabama at Birmingham joins the Kerafast Community.
• Weilin L Shelver, PhD, of United States Department of Agriculture contributes Thiamethoxam Antibodies .
• Michael Zeschnigk, PhD, of University of Duisburg-Essen contributes Monosomy 3 Uveal Melanoma Cell Lines.
• Mark A. Knepper, MD, PhD, of National Heart, Lung, and Blood Institute/NIH contributes Aquaporin 2 (AQP2) [K5007] Antibody.
• Nicole S. Sampson, PhD, of Stony Brook University contributes AROMP Compunds.
• University of Quebec at Montreal joins the Kerafast Community.

April 2018

• Steven R. Grossman, MD, PhD, of Virginia Commonwealth University contributes CtBP1 [CG14] Antibody.
• Eishi Noguchi, PhD, of Drexel University contributes pFA6A-GFP-ura4MX6 Plasmid.
• Mauricio J. Reginato, PhD, of Drexel University contributes PC3-ML-Luciferase Prostate Cancer Cell Line.
• Cellomics Technology contributes additional Premade Lentiviruses.
• Stanford University joins the Kerafast Community.
• Ronald P. Mason, PhD, of National Institute of Environmental Health Sciences/NIH contributes Anti-DMPO [N1664A] Antibody.
• Brian J. Geiss, PhD, of Colorado State University contributes Zika Virus Plasmids.
• University of Duisburg-Essen joins the Kerafast Community.
• Jaime F. Modiano, VMD, PhD, of University Minnesota, Twin Cities contributes additional Canine Osteosarcoma Cell Lines.
• Drexel University joins the Kerafast Community.
• University of Arizona joins the Kerafast Community.
• Lynda F. Bonewald, PhD, of University of Missouri - Kansas City contributes Cementocyte-Like Cell Line (IDG-CM6).
• Nathan D. Lawson, PhD, of University of Massachusetts Medical School contributes Etv2, Fli1b, VEGFR3/Flt4, and VEGFR Kdrl/FLK-1 Antibodies.
• George Inana, MD, PhD, of University of Miami contributes Rat Retinal Pigment Epithelium Cell Line (BPEI-1).

March 2018

• United States Department of Agriculture/USDA joins the Kerafast Community.
• Darell D. Bigner, MD, PhD, of Duke University contributes EGFRvIII [L8A4] Antibody.
• Stanley M. Lemon, MD, of University of North Carolina Chapel Hill contributes Hepatitis A Virus Antibody and Expression Plasmid.
• Julie P. Deans, PhD, of University of Calgary contributs MS4A and CD20 expressing Cell Lines.
• Shibo Jiang, MD, PhD and Lanying Du, PhD, of New York Blood Center contribute additional SARS-CoV Receptor-Binding Domain (RBD) Antibodies.

February 2018

• Dominic Esposito, PhD, of National Cancer Institute/NIH contributes Trichoplusia ni Cell Line (Tni-FNL).
• Robert A. Nicholas, PhD, of University of North Carolina at Chapel Hill contributes P2Y Receptor Expressing Human Astrocytoma Cell Lines.
• William C. Copeland, PhD, of National Institute of Environmental Health Sciences/NIH contributes POLG Antibodies.
• Press Release: Absolute Antibody and Kerafast Merge to Increase Access to Unique Reagents and Recombinant Antibody Technology.
• Timothy L. Megraw, PhD, of Florida State University contributes Zika Virus Envelope (E) Protein Antibody.
• Martin Olivier, PhD, of McGill University contributes Bone Marrow Derived Macrophage (BMDM) Cell Lines.
• Rima Rozen, PhD, of McGill University contributes Methylenetetrahydrofolate Reductase (MTFR) Antibody.

January 2018

• University of Massachusetts Dartmouth joins the Kerafast Community.
• Kostas Pantopoulos, PhD, of McGill University contributes Aconitase (ACO1/IRP1) Antibody, DMT1 (SLC11A2) Antibody, Ferroportin (SLC40A1) Antibody, and Hemojuvelin (HFE2) Antibody.
• Fred Hutchinson Cancer Research Center joins the Kerafast Community.
• Mark R. Brown, PhD, of University of Georgia contributes Ecdysteroid E/20E Antibodies and Antigens.
• Michael G. Hahn, PhD, of University of Georgia contributes Rhamnogalacturonan I [CCRC-M79] Antibody.
• David M. Lucas, PhD, of The Ohio State University contributes Cereblon (CRBN) [3B12F7] Antibody.
• David G. Kaufman, MD, PhD, of University of North Carolina Chapel Hill contributes Human Endometrial Stromal Cell Line (SHT290).
• Mark R. Brown, PhD, of University of Georgia contributes Adiopokinetic Hormone (AKH) Antibody.

December 2017

• William A. Petri, Jr., MD, PhD and Ibne K. Ali, PhD, of University of Virginia contribute Cyst Wall-Specific Glycoprotein Jacob Antibodies.
• Jay C. Brown, PhD and William W. Newcomb, of University of Virginia contribute Herpes Simplex Virus Type 1 (HSV-1) Capsid Protein VP5 [6F10-D2-G2] Antibody.
• Oliver Kerscher, PhD, of College of William & Mary contributes KmUD SUMO Protease.
• Jay W. Fox, PhD and Rupert Timpl, PhD, of University of Virginia contribute Nidogen Antibodies.
• Thao P. Dang, MD, of University of Virginia contributes Notch 3 Antibodies.
• Barry M. Gumbiner, PhD, of University of Virginia contributes Cadherin-1 [19A11] Antibody.
• Ronald P. Taylor, PhD, of University of Virginia contributes additional Complement Antibodies.

November 2017

• Gail M. Seigel, PhD, of University at Buffalo contributes Rat Cochlear Microglial Cell Line (Mocha).
• Nicole Beauchemin, PhD, of , McGill University contributes Ceacam1/2 Antibodies.
• Darryl C. Zeldin, MD, of National Institute of Environmental Health Sciences/NIH contributes Cytochrome P450 2J2 (CYP2J2) Antibody.
• Scott H. Randell, PhD, of University of North Carolina at Chapel Hill contributes Human Bronchial Epithelial Cell Lines.
• Paul Knox, PhD, of University of Leeds contributes Plant Cell Wall Antibodies.
• Vladimir V. Popik, PhD, of University of Georgia contributes Novel strain-promoted alkyne-azide cycloaddition (SPAAC) Reagents.

October 2017

• Colorado State University joins the Kerafast Community.
• Nu Chemie, LLC adds NuLink Bioconjugation Reagents.
• University of Leeds joins the Kerafast Community.
• Marilyn R. Mackiewicz, PhD, of Portland State University contributes Functionalized Gold Nanoparticles.
• Shibo Jiang, MD, PhD and Lanying Du, PhD, of New York Blood Center contribute Influenza A (H5N1) Hemagglutinin (HA) Antibodies and SARS-CoV Receptor-Binding Domain (RBD) Antibodies.
• Mark S. Parcells, PhD, of University of Delaware contributes Zika Virus Antibodies and Marek's Disease Cell Lines.
• New York Blood Center joins the Kerafast Community.
• Terry D. Connell, PhD, of University at Buffalo contributes Heat-Labile Enterotoxins (HLTs).
• Rodger P. McEver, MD, of Oklahoma Medical Research Foundation contributes E-Selectin [ES1] Antibody and Integrin alpha-IIb (ITGA2B) [Tab, 8aB5-9-9-15] Antibody.
• Jay E. Brenman, PhD, of University of North Carolina Chapel Hill contributes PRKAA1/2 Antibodies.

September 2017

• Gerald W. Hart, PhD and Frank I. Comer, PhD, of The Johns Hopkins University contribute O-GlcNAc [CTD110.6] Antibody.
• Fengyi Wan, PhD, of The Johns Hopkins University contributes phospho Sam68/KHDRBS1, Ser113/117 Antibody.
• Yue Xiong, PhD, of University of North Carolina Chapel Hill contributes DDB1 Antibody and Ring-Box 1 (RBX1/ROC1C) Antibody.
• University of South Dakota joins the Kerafast Community.
• Jun Yong Kang, PhD, of University of Nevada Las Vegas contributes NHP-Butane and NHP-Thiourea Phosphonylation Reagents.
• Marko Radic, PhD, of University of Tennessee contributes Apoptosis (FUS/TLS) [LHC7.15] Autoantibody.

August 2017

• Samuel H. Wilson, MD and Robert W. Sobol, PhD, of National Institute of Environmental Health Sciences/NIH contribute DNA Damage/Repair Transformed MEF Cell Lines.
• Jin Wang, PhD, of Baylor College of Medicine contributes Mito-RealThiol Mitochondrial Glutathione (GSH) Detection Probe.
• Terry Magnuson, PhD, of University of North Carolina Chapel Hill contributes Triclosan Resistant (mFabI) Cloning Plasmid.
• Elizabeth M. Wilson, PhD, of University of North Carolina at Chapel Hill contributes MAGE-A11 Antibodies and Human Prostate Cancer Cell Line (CWR-R1).
• A. Bennett Jenson, MD and Shin Je Ghim, PhD, of University of Louisville contribute HPV18, Protein E7 [HPV E7-99] Antibody.
• Ulhas P. Naik, PhD, of Thomas Jefferson University contributes CIB1 [3C5] Antibody.
• Sui-Lam Wong, PhD, of University of Calgary contributes Streptavidin Mutein Matrix SAVSBPM18.
• Seth H. Pincus, MD, of Montana State University contributes Ricin Antibodies.

July 2017

• Dominic Esposito, PhD, of National Cancer Institute/NIH contributes Baculovirus AcMNPV Expressing E. coli Cell Line (DE35) and KRAS4b Baculovirus Expression Vectors.
• Ann M. Rothstein, PhD, of University of Massachusetts Medical School contributes Citrullinated Human Fibrinogen [10E9.3], mCherry [8C5.5], and Streptavidin [3A20.2] Antibodies.
• Megerditch (Mike) Kiledjian, PhD, of Rutgers University contributes Bacteriophage MS2 Coat Protein [3H4] Antibody.
• Justin M. Chalker, PhD, of University of Flinders contributes Polysulfide Polymer Mercury Sorbents.
• Ted M. Ross, PhD and Greg A. Kirchenbaum, PhD, of University of Georgia contribute Ferret B Cell Immunoglobulin Antibodies.
• Paula V. Monje, PhD, of University of Miami contributes Thy-1 Positive Rat Fibroblasts and Rat Epineurial Cells.
• Elly Nedivi, PhD, of Massachusetts Institute of Technology contributes CPG2 Antibodies.
• Jeffrey D. Erickson, PhD, of Louisiana State University Health Sciences Center New Orleans contributes NTT4, SNAT, and VGLUT Antibodies.
• Jin Wang, PhD, of Baylor College of Medicine contributes RealThiol Glutathione (GSH) Detection Probes.

June 2017

• Thomas Jefferson University joins the Kerafast Community.
• Lumiprobe adds additional Click Chemistry Reagents and Reactive Dyes.
• Larry W. Fisher, PhD, of National Institute of Dental and Craniofacial Research/NIH contributes additional MEPE, Fibromodulin, Versican, Biglycan, Sialophosphoprotein, Matrix Metalloproteinase, Dentin Matrix Protein 1, Osteopontin, Bone Sialoprotein, Collagen, Decorin, and Osteocalcin Antibodies.
• Francesco S. Celi, MD, of Virginia Commonwealth University contributes Mouse Inguinal Adipose SVF Preadipocyte Cell Line.
• Margarita Gutova, MD, of City of Hope contributes Human Neural Stem Cells (LM-NSC008).

May 2017

• Zhi-Ming Zheng, MD, PhD, of National Cancer Institute/NIH contributes SRp20 Expressing Tumorogenic MEF/3T3 Tet-Off Cell Line (MEF-T7-SRp20).
• Don J. Mahuran, PhD, of Hospital for Sick Children contributes Human GM2 Ganglioside.
• Richard B. Meagher, PhD, of University of Georgia contributes Actin-7 Antibodies.
• Melissa J. Caimano, PhD, of University of Connecticut contributes Flagellin (FlaB/BB0147) Antibody.
• Michael G. Hahn, PhD, of University of Georgia contributes additional Plant Cell Wall Antibodies.
• Larry L. Swift, PhD, of Vanderbilt University contributes Apolipoprotein B (ApoB) Antibodies.
• Paolo Serafini, PhD, of University of Miami contributes 4PD in vivo MDSC/Mφ Transfection Reagent.
• Benjamin G. Davis, PhD, of University of Oxford contributes FITC-Trehalose, Fluorescent Mycobacteria Probe.
• Christina T. Teng, PhD, of National Institute of Environmental Health Sciences/NIH contributes PGC-1α/ERRα Pathway HEK-293T Cell Lines.
• Ned A. Porter, PhD and Keri A. Tallman, PhD, of Vanderbilt University contribute additional Sterol and Oxysterol Derivitives and Sterol Isotopes.
• Arnon Lavie, PhD, of University of Illinois at Chicago contributes SUMO Protease Domain (Ulp1p, M1_K402del).
• Garrett M. Brodeur, MD, of Children's Hospital of Philadelphia contributes Trk-expressing NLF and SH-SY5Y cell lines.
• Abraham L Sonenshein, PhD, of Tufts University contributes Bacillus subtilis Antibodies.

April 2017

• Christoph Rader, PhD, of National Cancer Institute/NIH contributes pC3C Phage Display Plasmids.
• Jian-Ping Jin, MD, PhD, of Wayne State University contributes Ready-to-Use and Load PCR Master Mix.
• Dawen Cai, PhD, of University of Michigan contributes Anti-mCherry (Chicken) Antibody.
• Paula V. Monje, PhD, of University of Miami contributes Rat Primary Schwann Cells.
• Deborah French, PhD, of Children's Hospital of Philadelphia contributes Human PBMC iPS Cell Line (CHOPWT10).
• Anton M. Jetten, PhD, of National Institute of Environmental Health Sciences/NIH contributes Cystic Fibrosis Human Bronchial Epithelial Cell Line (CF/T43).
• David R. Lynch, MD, PhD, of Children's Hospital of Philadelphia contributes Friedreich's Ataxia Skin Fibroblast Cell Lines.
• Ned A. Porter, PhD and Keri A. Tallman, PhD, of Vanderbilt University contribute Sterol and Oxysterol Derivitives and Sterol Isotopes.
• Peter Sutovsky, PhD, of University of Missouri-Columbia contributes TXNDC8 (SPTRX-3) Antibody.
• University of South Alabama joins the Kerafast Community.

March 2017

• Susumo Tomita, PhD, of Yale University contributes Stargazin-like TARP (CACNG2) Antibody.
• Arthur R. Hand, DDS and Maija Mednieks, PhD, of University of Connecticut contribute PKA-RII (PRKAR2A) Antibody.
• National Institute of Environmental Health Sciences/NIH joins the Kerafast Community.
• Clemson University joins the Kerafast Community.
• Paul Dent, PhD, of Virginia Commonwealth University contributes NSCLC Patient Derived Xenograft (ADOR).
• Meenhard Herlyn, DVM, DSc, of The Wistar Institute contributes pLU-CMV-GFP-pBLAST Lentiviral Control Plasmid.
• Michael J. Matunis, PhD, of The Johns Hopkins University contributes SUMO2/SUMO3 [8A2] Antibody.
• Jean-Paul Lellouche, PhD, of Bar-Ilan University contributes Lanthanide Ce3/4+ cation/complex-Doped Fe2O3 Nanoparticles.
• Geert-Jan Boons, PhD, Lance Wells, PhD, and Margreet A. Wolfert, PhD, of University of Georgia contribute O-linked N-acetylglucosamine (O-GlcNAc) Antibodies.

February 2017

• Edward K. Chan, PhD, of University of Florida contributes Argonaute-2 (AGO2) [4F9] Antibody.
• Carl W. Bergmann, PhD and Ronald P. Clay, PhD, of University of Georgia contribute Cochliobolus Endopolygalacturonase (EPG) Antibodies.
• Pradip Raychaudhuri, PhD, of University of Illinois at Chicago contributes Cullin-4A (CUL4A) Antibody and FoxM1b, C-Terminal Antibody.
• Victoria P. Belancio, PhD, of Tulane University contributes LINE-1 Retrotransposable Element ORF2 Protein [1G4E11] Antibody.
• Kyoungjin J. Yoon, DVM, PhD, of Iowa State University contributes Porcine Rotavirus VP6 Antibodies.
• Lee H. Pratt, PhD and Marie-Michelle Cordonnier Pratt, PhD, of University of Georgia contribute Phytochrome Antibodies.
• Tulane University joins the Kerafast Community.
• Richard F. Lee, PhD, of University of Georgia contributes Lipoprotein (LpI) and Lipovitellin II LpA Antibodies.

January 2017

• Donghoon Chung, PhD, of University of Louisville contributes Zika Virus Envelope (E) Protein, ED3 Domain [3E10D1] Antibody.
• Kelley W. Moremen, PhD, of University of Georgia contributes Golgi Alpha-Mannosidase 2 Antibody.
• Richard B. Meagher, PhD, of University of Georgia contributes Phytochelatin Synthase Antibodies.
• Bar-Ilan University joins the Kerafast Community.
• Frank T. Robb, PhD, of University of Maryland, Baltimore contributes Hyperstable, Extremophile Chaperone Proteins.
• Clonegene adds Influenza A, Nucleoprotein [HB65] Antibody, PD-1 Antibodies, HuR (ELAVL1) [19F12] Antibody, Cluster of Differentiation Antibodies, and EGFR [225] Antibody.
• University of New Hampshire joins the Kerafast Community.
• Dominic Esposito, PhD, of National Cancer Institute/NIH contributes ffLuc2-eGFP Expressing Lentivirus Vectors.
• Richard B. Meagher, PhD, of University of Georgia contributes Glutathione Synthase (GSH) Antibodies and Gamma-Glutamylcysteine Synthetase (γ-ECS) Antibodies.
• SwissAustral USA, LLC contributes contributes Recombinant Microbial Catalase (Lyophilized Powder).
• David M. Segal, PhD, of National Cancer Institute/NIH contributes TLR3, Extracellular Domain [11F8.1B7] Antibody.
• Ken Mackie, MD, of Indiana University contributes CB1, CB2, and GPR55 Cannabinoid Receptor Expressing HEK293 Cell Lines.
• Richard B. Meagher, PhD, of University of Georgia contributes ARP6 and ARP8 Antibodies.
• Edward T. Kipreos, PhD, of University of Georgia contributes CYE-1 [17C8] Antibody.
• Susan Wong of National Heart, Lung, and Blood Institute/NIH contributes Human CD36+ Erythroid Progenitor Cell Line (CD36E).
• University of Georgia contributes Fusarium spp. [1F8] Antibody and Neotyphodium Coenophialum (Strain AR542) Antibodies.
• Steven L. Stice, PhD, of University of Georgia contributes Chicken Induced Pluripotent Stem Cells (BA3).
• Mary Custer of National Cancer Institute/NIH contributes Kai1 (CD82) [M35] Antibody.

December 2016

• Laura S. Schmidt, PhD, of National Cancer Institute/NIH contributes additional Murine MET Expressing NIH3T3 Cell Lines.
• Curtis C. Harris, MD, of National Cancer Institute/NIH contributes additional Human Bronchial Epithelial Cell Line (BEAS-2B).
• Dominic Esposito, PhD, of National Cancer Institute/NIH contributes Sf-9 Easy Titer Cell Line (Sf-9 ET).

October 2016

• Larry W. Fisher, PhD, of National Institute of Dental and Craniofacial Research/NIH contributes additional Biglycan, Decorin, and Collagen Antibodies.
• Harry A. Dailey, PhD, of University of Georgia contributes additional ALAS2, PPOX, and FECH Antibodies.
• Michael G. Hahn, PhD, of University of Georgia contributes additional Plant Cell Wall Antibodies.
• David J. Earnest, PhD, of Texas A&M University contributes Rat Suprachiasmatic Nucleus Cell Line (SCN 2.2).
• National Institute of Dental and Craniofacial Research/NIH joins the Kerafast Community.

September 2016

• Texas A&M University joins the Kerafast Community.
• Elizabeth M. Boon, PhD, of Stony Brook University contributes Engineered Diguanylate Cyclase.
• Douglas A. Bayliss, PhD, of University of Virginia contributes Rat Task Expressing CHO Cell Lines.
• David A. Tulis, PhD, FAHA and William E. Howard, PhD, of East Carolina University contribute Residue-Free 3D Printed Cell Culture Inserts.
• Janet Holliday, PhD, of University of Rochester contributes Cerebellar Granule Cell Line (Cb-E1A).
• Cancer Research Technology contributes Human Norrin Protein.

August 2016

• Claus-Peter Czerny, DVM, of University of Göttingen contributes Orthopoxvirus Antibodies, Canarypox Virus Antibody, and Coronavirus Antibody.
• Abdul Waheed, PhD, of St. Louis University contributes Hereditary Hemochromatosis Protein (HFE) Antibody, Sodium Bicarbonate Cotransporter Antibodies, and Transferrin Receptor 2 Antibody.
• Benhur Lee, MD, of Icahn School of Medicine at Mount Sinai contributes Sendai Virus Antibodies.
• Kate Carroll, PhD, of The Scripps Research Institute contributes Cysteine Sulfenic Acid (2-Thiodimedone) Antibody, CN-Alkyne Sulfenic Acid Probe, NO2-Alkyne Sulfenic Acid Probe, and PTP-S-Dimedone Antibody.
• Abdul Waheed, PhD, of St. Louis University contributes Rhodopsin Antibodies and Carbonic Anhydrase Antibodies.
• Wei Hsu, PhD, of University of Rochester contributes Wnt Pathway Plasmids.
• Gerard Zurawski, PhD, of Baylor Scott & White Research Institute contributes AMIGO2 [30G9.1G2] Antibody.
• Jianming Hu, MD, PhD, of Penn State College of Medicine contributes Hepatitis B Virss Mammalian Expression Plasmids.
• Clonegene adds Anti-Flavivirus Envelope (E) Protein [D1-4G2-4-15] Antibody, Anti-GFP Tag [CG099] Antibody, Anti-GST [5C12] Antibody, and Recombinant HuD/ELAVL4 Neoantigens.

July 2016

• David I. Yule, PhD, of University of Rochester contributes IP3R Expressing HEK-293 Cell Lines.
• Flinders University joins the Kerafast Community.
• Domenico Tortorella, PhD, of Icahn School of Medicine at Mount Sinai contributes Human Cytomegalovirus gB [5A6] Antibody.

June 2016

• Marianne Wessling-Resnick, PhD, of Harvard University contributes DMT1 Expressing HEK293 Cell Line.
• Norbert Perrimon, PhD, PhD, of Harvard University contributes Drosophila Adult Muscle Progenitor-like Cell Lines.
• Domenico Tortorella, PhD, and Thomas M. Moran, PhD, of Icahn School of Medicine at Mount Sinai contribute Alpha-2-Macroglobulin [5C11] Antibody and Integrin Alpha-3 [6E2] Antibody.
• Chi Li, PhD, of University of Louisville contributes Human Bcl-xL Cell Lines and Plasmids.
• Anumantha G. Kanthasamy, PhD, of Iowa State University contributes PKC Delta [10F11B] Antibody.
• Wei Li, PhD, of University of Miami contributes Dual Phage Display E. coli Strains.
• Paolo Serafini, PhD, of University of Miami contributes 4PD in vivo MDSC/Mφ Transfection Reagent.
• David L. Paul, PhD, of Harvard University contributes Connexin-32 [M12.13] Antibody.
• Michael G. Hahn, PhD, of University of Georgia contributes additional Plant Cell Wall Antibodies.
• SwissAustral USA, LLC contributes contributes Recombinant Microbial Glutamate Dehydrogenase (GDH).

May 2016

• Edward Perez-Reyes, PhD, of University of Virginia contributes LVA Ca²⁺ Channel Ca_v3 Cell Lines.
• William L. Ragland, PhD, of University of Georgia contributes Avian Thymic Hormone (ATH) [4A6] Antibody.
• Robert M. Strongin, PhD, of Portland State University contributes Large Stokes-Shift NIR Dyes, Fluorescent Lysophosphatic Acid (LPA) Detection Agent, and Fluorogenic Cysteine/Homocsteine Detection Agents.
• Vikram Misra, PhD, of University of Saskatchewan contributes Eptesicus fuscus Kidney Cell Line (Efk3B).
• Brian K. Kay, PhD, of University of Illinois at Chicago contributes various FN3 Monobodies.
• Michael G. Hahn, PhD, of University of Georgia contributes Sycamore Xyloglucan [CCRC-M102] Antibody, Tomato Xyloglucan [CCRC-M96] Antibody, and P. cookianum Xylan [CCRC-M113] Antibody.
• Baylor Scott & White Research Institute joins the Kerafast Community.
• Jorrit M. Enserink, PhD, of University of Oslo contributes GST-PAK-CRIB Rac/Cdc42 Isolation Kit.
• Iowa State University contributes Clostridium Perfringens Epsilon Toxin [4D6] Antibody.
• University of Reading joins the Kerafast Community.
• Tom Misteli, PhD, of National Cancer Institute/NIH contributes U2OS-LacO-I-SceI-TetO Cell Line.
• Kate Carroll, PhD, of The Scripps Research Institute contributes DYn-2 Sulfenic Acid Probe.
• James R. Yankaskas, MD, of University of North Carolina at Chapel Hill contributes Bronchial Epithelial Cell Lines (CFT1 & HBE1).
• Portland State University joins the Kerafast Community.
• Press Release: Kerafast adds new Zika virus antibody to its catalog of novel life science reagents.
• Alec H. Sehon, PhD, of University of Manitoba contributes Biotin [33] Antibody.
• University of Saskatchewan joins the Kerafast Community.

April 2016

• Yoav Gothilf, PhD, of Tel Aviv University contributes Zebrafish Circadian Clock Model Analysis Services.
• Ronit Satchi-Fainaro, PhD, of Tel Aviv University contributes Cancer Angiogenesis and Nanomedicine Services.
• Vered Padler-Karavani, PhD, of Tel Aviv University contributes Glycoimmunology Services.
• Gerardo Z. Lederkremer, PhD, of Tel Aviv University contributes Endoplasmic Reticulum Related Services.
• Peer Dan, PhD, of Tel Aviv University contributes Nanoparticle Generation Services.
• Amit Gefen, PhD, of Tel Aviv University contributes Musculoskeletal Biomechanics Services.
• Daniel H. Conrad, PhD, of Virginia Commonwealth University contributes FcγRI (CD64) Expressing CHO Cell Line (mRG1) and IgE [R1E4] Antibody.
• Tel Aviv University joins the Kerafast Community.
• David I. Yule, PhD, of University of Rochester contributes IP3R Null HEK-293 Cell Line (HEK-3KO).
• Eckhard R. Podack, MD, PhD, of University of Miami contributes TL1A [L4G6] Antibody.
• Kefei Yu, PhD, of Michigan State University contributes CH12F3 B Lymphocyte Cell Lines.
• Kate Carroll, PhD, of The Scripps Research Institute contributes Dimedone-d6 Sulfenic Acid Quantification Probe.
• University of Georgia contributes Nonspecific Cytotoxic Cell Receptor Protein [5C6] Antibody, Nonspecific Cytotoxic Cell Receptor Protein [6D3] Antibody, NC-37 Cell, NK Cell Mediated Lysis Inhibitory [18C2] Antibody, and NC-37 Cell, NK Cell [7C6] Antibody.
• University of Oslo joins the Kerafast Community.
• Catherine K. L. Too, PhD, of Dalhousie University contributes Carboxypeptidase D Antibody and Steroid 5-alpha-reductase 1 (SRD5A1) Antibody.
• James H. Morrissey, PhD, of University Illinois at Urbana-Champaign contributes Biotinylated Polyphosphate, Medium Chain (p100).

March 2016

• Michael G. Hahn, PhD, of University of Georgia contributes Rhamnogalacturonan I (Unbranched) Backbone [CCRC M14] Antibody and Rhamnogalacturonan I (Unbranched) Backbone [CCRC M36] Antibody.
• University of Florida joins the Kerafast Community.
• James E. Crowe Jr., MD, of Vanderbilt University contributes Zika Virus Envelope (E) Protein Antibody.
• Douglas A. Julin, PhD, of University of Maryland, College Park contributes RecBCD Expression Plasmid.
• University of Maryland, College Park joins the Kerafast Community.
• Martin Oppermann, MD, of University Medical Center Göttingen contributes Complement System and Beta-Arrestin Antibodies.
• Stanley H. Kleven, DVM, PhD and Maricarmen García, PhD, of University of Georgia contributes Mycoplasma gallisepticum Surface Epitope Antibodies.
• University of Göttingen joins the Kerafast Community.

February 2016

• Yi Lu, PhD, of University of Illinois at Urbana-Champaign contributes Redox Potential-Tuned Azurin Proteins.
• Mark W. Jackwood, PhD, of University of Georgia contributes B. avium 41-kDa Surface Protein Antibodies.
• Click Chemistry Tools adds additional Tetrazine-TCO Ligation Chemistry Reagents.
• University Medical Center Göttingen joins the Kerafast Community.
• Jeffrey Schlom, PhD and James W. Hodge, PhD, MBA, of National Cancer Institute/NIH contribute MC-38 Parental Cell Line.
• Kevin M. Coombs, PhD, of University of Manitoba contributes Influenza A, Non-Structural Protein 1 (NS1) Antibodies.
• Cellomics Technology adds additional Premade Lentiviruses.
• University of Manitoba joins the Kerafast Community.
• David W. Speicher, PhD, of The Wistar Institute contributes Spectrin, Filamin-A, Beta-Actin, and MelCAM/MUC18 Antibodies.
• Ramin Shiekattar, PhD, of The Wistar Institute contributes BHC110/LSD1 Antibody.
• Robert J. Hogan, PhD and Eric R. Lafontaine, PhD, of University of Georgia contribute Burkholderia mallei BpaB [BpaB#4] Antibody.
• Click Chemistry Tools adds additional Cy Conjugates.
• Dalhousie University joins the Kerafast Community.
• Chih-Hao Lee, PhD, of Harvard University contributes Microglial Cell Line (IMG).
• Donald A. Harn, PhD, of University of Georgia contributes LNFPIII/Lewis X (CD15) [E.5] Antibody.

January 2016

• Mary L. Taub, PhD, of University at Buffalo contributes Renal Proximal Tubule Cell Line (RPT-I8) and Serum-Free DME/F12 Medium.
• Click Chemistry Tools adds Cleavable Click Biotin Reagents.
• North Carolina State University joins the Kerafast Community.
• Frederick Sachs, PhD, of University at Buffalo contributes Actin Force Sensor Expressing Cell Lines.
• Click Chemistry Tools adds Azide/Alkyne Saccharides, Click Biotin/Streptavidin Reagents, and Click Chemistry Purification Kits.
• Meenhard Herlyn, DVM, DSc, of The Wistar Institute contributes pLU-JARID1B promoter-EGFP Lentiviral Plasmid.
• W. Clay Brown, PhD, of University of Michigan contributes pMocr (6xHis-Mocr tag) Plasmid.
• John W. Frost, PhD, of Michigan State University contributes Shikimate Pathway Related Compounds.
• Abdul Waheed, PhD, of St. Louis University contributes various Carbonic Anhydrase Antibodies.

December 2015

• Click Chemistry Tools adds Azide/Alkyne Magnetic Beads, Azide/Alkyne Agarose, and Alkynyl Myristic Acid.
• Meenhard Herlyn, DVM, DSc, of The Wistar Institute contributes various Cancer Antibodies.
• Wei Hsu, PhD, of University of Rochester contributes Wntless/Gpr177 Expression and in situ Hybridization Plasmids.
• Richard S. Hussey, PhD and Lee H. Pratt, PhD, of University of Georgia contribute Meloidogyne spp. Antibodies.
• Click Chemistry Tools contributes Metabolic Labeling Reagents.
• C. Vijaya Kumar, PhD, of University of Connecticut contributes GlowDot Protein-Based Fluorescent Nanoparticles.
• Feng Qian, PhD, of The John Hopkins University contributes Rabbit and Chicken Anti-Mouse C-Terminal Polycystin-1 Antibodies.
• Click Chemistry Tools contributes Cu Chelating Click Chemistry Reagents.
• Branson W. Ritchie, DVM, PhD, of University of Georgia contributes Psittacine Beak and Feather Disease (PBFD) Virus Antibodies.
• Click Chemistry Tools contributes Click Chemistry Reaction Kit.
• Steven Grant, MD, of Virginia Commonwealth University contributes IM Resistant ALL Cell Line (BV173/E255K).
• Click Chemistry Tools contributes Protein Conjugation Kits.
• Click Chemistry Tools contributes Bis-sulfone Conjugation Reagents.
• Roberto Docampo, MD, PhD, of University of Georgia contributes Trypanosoma cruzi CRISPR/Cas9 System.
• Royal A. McGraw, PhD, of University of Georgia contributes Tumor Necrosis Factor Antibodies.

November 2015

• Michael J. Adang, PhD, of University of Georgia contributes Anopheles gambiae Antibodies.
• Jaime F. Modiano, VMD, PhD, of University Minnesota, Twin Cities contributes additional Canine Hemangiosarcoma Cell Line (JHE).
• Jeffrey Schlom, PhD and James W. Hodge, PhD, MBA, of National Cancer Institute/NIH contribute MC-38 Cell Lines.
• Gloria S. Tannenbaum, PhD, of McGill University contributes growth hormone-related antibodies.
• Vibha Srivastava, PhD, of University of Arkansas, Division of Agriculture contributes Marker-Free Transgenic Plant Vectors pNS13 and pNS14.
• John L. Sherwood, PhD, of University of Georgia contributes Tomato Spotted Wilt Virus (TSWV), Nucleocapsid Protein [NH3-E5] Antibody.
• Donald A. Harn, PhD, of University of Georgia contributes S. mansoni Circulating Cathodic Antigen Antibodies.
• Frank J. Rauscher, III, PhD, of The Wistar Institute contributes phospho TIF1-beta (KAP1) Antibody and BAP1 Antibodies.
• Yuri K. Peterson, PhD, of Medical University of South Carolina contributes G Protein Alpha i Inhibitor (Tat-GPR).
• Frank J. Rauscher, III, PhD, of The Wistar Institute contributes AJUBA [3198] Antibody and LIMD1/2 Antibodies.
• Kim S. Wise, PhD, of University of Missouri - Columbia contributes Histone [F152C25W] Universal Antibody and M. hyorhinis P70 [AB3P] Antibody.
• Michael J. Adang, PhD, of University of Georgia contributes M. sexta Cry1Ac Aminopeptidase Antibodies.

October 2015

• Christian L. Lorson, PhD, of University of Missouri - Columbia contributes Survival Motor Neuron (SMN) Antibodies.
• Wei Hsu, PhD, of University of Rochester contributes Wntless/Gpr177 Antibody.
• Marc-Jan Gubbels, PhD, of Boston College contributes Toxoplasma gondii Centrin-1 Antibody.
• Richard B. Meagher, PhD, of University of Georgia contributes Mercuric Reductase (MerA) and Organomercurial Lyase (MerB) Antibodies.
• Hilary Koprowski, MD and Tadeusz J. Wiktor, DVM, of The Wistar Institute contribute Rabies Virus Glycoprotein and Nucleoprotein Antibodies.
• Thomas M. Moran, PhD, of Icahn School of Medicine at Mount Sinai contributes Influenza B Panama/45/90, Hemagglutinin (HA) [21C3] Antibody and Influenza B Panama/45/90, Neuraminidase [129A11] Antibody.
• Timothy M. Dore, PhD and James D. Lauderdale, PhD, of University of Georgia contribute Photoactivatable Serotonin (BHQ-O-5HT).
• Yiping Qi, PhD, of East Carolina University contributes Plant CRISPR/Cas9 Toolbox.
• Peter Palese, PhD, Adolfo Garcia-Sastre, PhD, Christopher F. Basler, PhD, and Thomas M. Moran, PhD, of Icahn School of Medicine at Mount Sinai contribute Influenza A (H1N1) Hemagglutinin Antibodies.

September 2015

• Karl Riabowol, PhD, of University of Calgary contributes ING1, ING3, and ING4 Antibodies.
• Extem Bioscience contributes Human Bone Marrow Mesenchymal Stem Cells (hBM-MSCs).
• John L. Sherwood, PhD, of University of Georgia contributes Tomato Spotted Wilt Virus (TSWV) Glycoprotein Antibodies.
• Dawen Cai, PhD, of University of Michigan contributes Brainbow Antibodies.
• Oliver Kerscher, PhD, of College of William & Mary contributes U-tag SUMO Trapping Protein.
• Sui-Lam Wong, PhD, of University of Calgary contributes Reversible Streptavidin Protein SAVSBPM18.
• Scott L. Friedman, MD, of Icahn School of Medicine at Mount Sinai contributes TLR4-/- Mouse Hepatic Stellate Cells Expressing WT TLR4.
• Michael A. Whitt, PhD, of University of Tennessee contributes additional Delta-G-VSV Pseudotyping System.
• John L. Sherwood, PhD, of University of Georgia contributes Tomato Spotted Wilt Virus (TSWV) Non-Structural Protein and Nucleocapsid Antibodies.

August 2015

• Tom Misteli, PhD, of National Cancer Institute/NIH contributes NIH 3T3 Cell Lines.
• Virginia Commonwealth University joins the Kerafast Community.
• Press Release: Kerafast Partners with the National Cancer Institute (NCI) – Enables Sharing of NCI Research Materials through Kerafast platform.
• James E. Crowe, Jr., MD, of Vanderbilt University contributes CD40L Expressing Feeder Cell Line (EL-4-B5).
• City University of New York joins the Kerafast Community.
• James N. Wilson, PhD, of University of Miami contributes Dual (Nuclear/Cytosolic) Fluorescent Probes.
• The Johns Hopkins University joins the Kerafast Community.
• University of Southern Mississippi joins the Kerafast Community.
• Howard Green, MD, of Harvard University contributes 3T3-J2 Cell Line, MMMbz Cell Line, and 3T3 Preadipose Cell Lines.
• Kate Carroll, PhD, of The Scripps Research Institute contributes NO-Bio Sulfinic Acid Probe.
• Julie P. Deans, PhD, of University of Calgary contributes CD20/MS4A Antibodies.
• Marvin J. Fritzler, MD, PhD, of University of Calgary contributes Vesicular Trafficking Antibodies.
• Abraham L. Brass, MD, PhD, of University of Massachusetts Medical School contributes Anti-dsRNA [rJ2] Antibody and Anti-PRRT2 Antibody.

July 2015

• University of Calgary joins the Kerafast Community.
• Cancer Research Technology contributes additional Anti-Cancer Compunds.
• Jaime F. Modiano, VMD, PhD, of University Minnesota, Twin Cities contributes Canine Melanoma and Hemangiosarcoma Cell Lines.
• Margarethe E. Hoenig, PhD, of University of Georgia contributes Anti-Proinsulin Antibodies.
• Wayne A. Parrott, PhD, of University of Georgia contributes pMeca Plasmid.
• Abraham Pinter, PhD, of Rutgers University contributes Anti-MuLV Transmembrane Protein [42/114] Antibody.
• Jaime F. Modiano, VMD, PhD, of University Minnesota, Twin Cities contributes Canine Osteosarcoma Cell Lines.

June 2015

• National Cancer Institute/NIH joins the Kerafast Community.
• Mark Howarth, PhD, of University of Oxford contributes SpyTag/SpyCatcher Protein Coupling Reagents.
• Estelle Leclerc, PhD, of North Dakota State University contributes Anti-RAGE, V Domain [2A11] Antibody.
• North Dakota State University joins the Kerafast Community.
• Michael G. Hahn, PhD, of University of Georgia contributes additional Plant Carbohydrate Antibodies.
• Ethan W. Taylor, PhD, of University of Georgia contributes CD4 Antibodies.
• Bruce R. Ksander, PhD, of Schepens Eye Research Institute contributes Uveal Melanoma Cell Line (MEL202).
• Lynda Bonewald, PhD, of University of Texas Health Science Center at San Antonio contributes Murine Osteocyte-like Cell Lines MLO-A5 and Murine Osteocyte-like Cell Lines MLO-Y4.
• University of Texas Health Science Center at San Antonio joins the Kerafast Community.
• Douglas L. Feinstein, PhD, of University of Illinois at Chicago contributes Astrocyte LKB1 KO Cell Line.
• Arnon Lavie, PhD, of University of Illinois at Chicago contributes Guinea pig L-Asparaginase and Human Deoxycytidine Kinases.
• Cell Resource Core, of Massachusetts General Hospital contributes Hepatocyte Primary Cells and Reagents.

May 2015

• Terri Goss Kinzy, PhD, of Rutgers University contributes eEF Antibodies and Expression Strain.
• Michael G. Hahn, PhD, of University of Georgia contributes Plant Carbohydrate Antibodies.
• Massachusetts General Hospital Cell Resource Core joins the Kerafast Community.
• Ann Hochschild, PhD, of Harvard University. contributes C-DAG Amyloidogenicity Kit.
• Feng Qian, PhD, and Terry J. Watnick, MD, of University of Maryland, Baltimore contribute Polycystin-1 Antibodies.
• Alexander K. Murashov, MD, PhD, of East Carolina University contributes Mouse Cortico-Hippocampal Neurons.
• Ronald P. Taylor, PhD, of University of Virginia contributes Complement C3b-iC3b Antibodies.
• Walter J. Chazin, PhD, of Vanderbilt University contributes Human S100A8/A9 Heterodimer (Calprotectin).
• H.B. Custom Media, Inc. contributes Custom Media Service.

April 2015

• Paul A. Grieco, PhD, of Montana State University contributes Thiosulfonate Switch Reagents.
• Bruce R. Ksander, PhD, of Schepens Eye Research Institute contributes Retinoblastoma Cell Lines.
• Christopher F. Basler, PhD, of Icahn School of Medicine at Mount Sinai contributes Zaire Ebola Virus Antibodies.
• Anne G. Savitt, PhD, of Stony Brook University contributes F. tularensis LVS Antibodies.
• Ned A. Porter, PhD and Keri A. Tallman, PhD, of Vanderbilt University contribute Alkynated Cholesterol Derivatives.
• Thomas M. Moran, PhD, of Icahn School of Medicine at Mount Sinai contributes GST [22A6] Antibody.
• Mark A. Eiteman, PhD, of University of Georgia contributes Metabolically Engineered E. coli Strain ALS1122.
• Leif Oxburgh, DVM, PhD, of Maine Medical Cancer Research Institute contributes Nephron Progenitor Cells & Medium.
• Mary Ann Moran, PhD, Andrew S. Burns, PhD and Adam Rivers, PhD, of University of Georgia contributes Biotinylated sRNA Ladder.
• Richard D. Sjolund, PhD, of University of Iowa contributes Phloem Sieve Element Antibody.

March 2015

• Kumi Nagamoto-Combs, PhD, of University of North Dakota contributes Microglial Cell Line (SIM-A9).
• Thomas P. Brutnell, PhD, of Donald Danforth Plant Science Center contributes KAZU DNA Extraction Buffer.
• Constance E. Brinckerhoff, PhD, of Dartmouth College contributes Malignant Melanoma Cell Line (D4M).
• Nu Chemie contributes Functionalized PLGA Nanoparticles.
• Kezhong Zhang, PhD, of Wayne State University contributes CREB-H (CREB3L3) Antibody.
• Donald Danforth Plant Science Center joins the Kerafast Community.
• Binghamton University joins the Kerafast Community.
• Press Release: Kerafast and The Wistar Institute Announce Collaboration through the Kerafast Fellows Program.
• Martin A. Schwartz PhD, of University of Virginia contributes RhoG [1F3-B3-E5] Antibody and Zizimin1 [8B3-C3-E4] Antibody.
• Amy Bouton, PhD and J. Thomas Parsons, PhD, of University of Virginia contribute p130 Cas (BCAR1) [8G4-E8] Antibody.
• University of North Dakota joins the Kerafast Community.
• J. Thomas Parsons, PhD, Sarah (Sally) J. Parsons, PhD, and Albert B. Reynolds, PhD, of University of Virginia contribute p120 Catenin [2B12] Antibody and Phosphotyrosine [6G9] Antibody.
• Monica J. Roth, PhD, of Rutgers University contributes Moloney Murine Leukemia Virus (M-MuLV) Plasmids.
• Ming-Sound Tsao, MD, of University Health Network, Canada contributes Human Pancreatic Duct Epithelial Cell Line (H6c7).
• Michael J. Weber, PhD, of University of Virginia contributes MAP kinase 2/Erk2 [1B3B9] Antibody.
• Tamas Nagy, DVM, PhD, of University of Georgia contributes Mouse, Rat, and Dog Tissue Samples.

February 2015

• Schickwann Tsai, MD, PhD, of University of Utah contributes Natural Killer Cell Line (KIL).
• Stephen H. Leppla, PhD, of National Institutes of Health/NIAID contributes Anthrax Protein Variants.
• K. Kevin Pfister, PhD, of University of Virginia contributes DYNLT1 and DYNLT3 Antibodies.
• Gordon W. Laurie, PhD, Rebecca A. Ogle, PhD, and J. Douglas Glass, MD, of University of Virginia contribute BM180 [3E12] Antibody.
• Kate Carroll, PhD, of The Scripps Research Institute contributes DYn2-d6 Sulfenic Acid Probe.
• Iowa State University contributes M. hyopneumoniae Ciliary Adhesion Protein P97 [F1B6] Hybridoma.
• Alison J. Quayle, PhD, of LSU Health Sciences Center contributes Human Endocervical Epithelial Cell Line.
• Roy L. Silverstein, MD, of Cornell University contributes Mouse CD36 [JC-63] Antibody.
• Cancer Research Technology contributes additional Cancer-Related Antibodies.
• The Wistar Institute joins the Kerafast Community.
• Stony Brook University joins the Kerafast Community.
• SwissAustral USA, LLC contributes contributes Extremophile Reagents and Services.
• Thomas M. Moran, PhD and Luis Martinez-Sobrido, PhD, of Icahn School of Medicine at Mount Sinai contributes Metapneumovirus (hMPV) [15E4H8] Antibody.

January 2015

• University Health Network, Canada joins the Kerafast Community.
• Gladys Alexandre, PhD, of University of Tennessee contributes Slide-In Plant Chamber.
• Ned A. Porter, PhD and Keri A. Tallman, PhD, of Vanderbilt University contribute Alkyne-Fatty Acids and Alkyne-Lipid Oxidation Products.
• John W. Steinke, PhD, Larry C. Borish, MD, and S. Brandon Early, of University of Virginia contribute Human Mast Cell Line (LUVA).
• Richard H. Aster, MD, of Blood Center of Wisconsin contributes Integrin Alpha-IIb, Integrin Beta 3, and Platelet Factor 4 Antibodies.
• Peter J. Sims, MD, PhD, of Blood Center of Wisconsin contributes Anti-PLSCR1 Hybridomas.
• Peter J. Newman, PhD, of Blood Center of Wisconsin contributes PECAM-1 Antibodies.
• Amitabha Bandyopadhyay, PhD, of Indian Institute of Technology Kanpur contributes BMP Responsive Reporter Osteoblast Cell Line.
• Ned A. Porter, PhD and Keri A. Tallman, PhD, of Vanderbilt University contribute Biotinylated Click Chemistry Probes.

December 2014

• Mark A. Eiteman, PhD, of University of Georgia contributes Metabolically Engineered E. coli Strains.
• Robert T. Dirksen, PhD, of University of Rochester contributes RyR1 Expressing HEK293 Cell Line.
• Medical University of South Carolina joins the Kerafast Community.
• Aneel K. Aggarwal, PhD, of Icahn School Of Medicine at Mount Sinai contributes Anti-DNA Polymerase Eta [2A10] Antibody.
• Dhan V. Kalvakolanu, PhD, University of Maryland, Baltimore contributes Anti-GRIM-19 [1A8] Antibody.
• Richard B. Meagher, PhD, of University of Georgia contributes Anti-LacI [15C11] Antibody and Anti-LacI [17D5] Antibody.
• Algirdas J. Jesaitis, PhD, of Montana State University contributes Anti-FPR1 [NFPRb] Antibody and Anti-FPR1/2 [NFPRa] Antibody.
• Stop by and visit us at American Society for Cell Biology 2014, Booth 308 in Philadelphia, PA 12/6/14 - 12/10/14.
• Scott L. Friedman, MD, of Icahn School of Medicine at Mount Sinai contributes TLR4 SNP Expressing Mouse Hepatic Stellate Cell Lines.
• Elegant Instruments, LLC contributes Versatool Kit for Cryosectioning.

November 2014

• Timothy E. Glass, PhD, of University of Missouri - Columbia contributes Fluorescent Neurotransmitter Exocytosis Probe (ES517) and Fluorescent Norepinephrine Probe (NS521).
• Jerry T. Thornthwaite, PhD, of Cancer Research Institute of West Tennessee contributes DNA Flow Cytometry Reagents.
• Paulo A. Ferreira, PhD, of Duke University contributes Red/Green (L/M) Opsin [21069] Antibody.
• James N. Wilson, PhD, of University of Miami contributes DNA-Binding Fluorescent Stains.
• Juliet M. Daniel, PhD, of McMaster University contributes pGEX-5X-1-Znf131 Plasmids and pGLuc-TATA KBS/ZBE Plasmids.
• Andrew D. Ellington, PhD, of University of Texas at Austin contributes Non-Natural Promoter T7 Polymerase.
• James H. Morrissey, PhD, of University Illinois at Urbana-Champaign contributes Biotinylated Polyphosphate, Long Chain and Polyphosphate, Medium Chain (p100).

October 2014

• Biotech Consortium India Limited joins the Kerafast Community.
• Benjamin G. Davis, PhD, of University of Oxford contributes Aqueous Palladium Catalyst and 2,5 dibromohexanediamide (DBHDA) Alkylating Agent.
• Kathleen C.M Campbell, PhD, of Southern Illinois University contributes Chinchilla Tissue Samples.
• University of Minnesota, Twin Cities joins the Kerafast Community.
• Sunnybrook Research Institute joins the Kerafast Community.
• William S. Trimble, PhD, FRSC, of Hospital for Sick Children contributes Septin 9 [10C10] Antibody.
• Kevin P. Campbell, PhD, of University of Iowa contributes Alpha Dystroglycan [VIA41] Antibody.
• Alireza R. Rezaie, PhD, of St. Louis University contributes Coagulation Cascade Protein Variants.

September 2014

• Carol F. Webb, PhD, of Oklahoma Medical Research Foundation contributes ARID3a/BRIGHT and TFII-I/BAP-135 Antibodies.
• Davide Comoletti DVM, PhD, of Rutgers University contributes Endoglycosidase F1 (Endo F1) and Peptide-N-Glycosidase F (PNGase F).
• Aaron Weinberg, DMD, PhD and Santosh K. Ghosh, PhD, of Case Western Reserve University contribute Oral Epithelial HIV Cell Line.
• Chi-chung Hui, PhD, of Hospital for Sick Children contributes Anti-IRX3 Antibody and Anti-IRX5 Antibody.
• University of Notre Dame joins the Kerafast Community.
• Darell D. Bigner, MD, PhD, of Duke University contributes U-251 MG Human Malignant Glioblastoma Multiforme Cell Line.
• Blood Center of Wisconsin joins the Kerafast Community.
• Michael A. Apicella, MD, of University Iowa contributes Francisella tularensis [11B7] Antibody.
• Press Release: Kerafast Announces The University of Texas at Austin as 100th Providing Institution.
• Southwood Scientific, LLC contributes Tissue Preservation Chamber.

August 2014

July 2014

• University of Miami joins the Kerafast Community.
• Subramaniam (Sri) Srikumaran, PhD, of Washington State University contributes Mouse Macrophage Cell Line [AA9] for PRRSV Propagation.
• Temple University joins the Kerafast Community.
• Lynda F. Bonewald, PhD, of University of Missouri - Kansas City contributes IDG-SW3 Bone Cell Line.
• University of Iowa joins the Kerafast Community.
• Helen Vlassara, MD, of Icahn School of Medicine at Mount Sinai contributes Advanced Glycation End products (AGE), Carboxy-Methyl Lysine (CML) - AGE-CML [6C7] Antibody and Advanced Glycation End products (AGE), Methylglyoxal (MG) - AGE-MG [3D11] Antibody.
• Louisiana State University Health Sciences Center Shreveport joins the Kerafast Community.
• Oklahoma Medical Research Foundation joins the Kerafast Community.
• George S. Bloom, PhD and Eva Ho-Man Kan, of University of Virginia contribute IQGAP2 [A2] Antibody.
• Southern Illinois University joins the Kerafast Community.
• Cornell University joins the Kerafast Community.
• Vijay Sarthy, PhD, of Northwestern University contributes Immortalized Retinal Muller Cell Line rMC-1.
• Michael A. Moxley, PhD and Abdul Waheed, PhD, of St. Louis University contribute Optimized ECL Reagent.
• University of Missouri - Kansas City joins the Kerafast Community.
• University of Texas at Austin joins the Kerafast Community.
• Benjamin G. Davis, PhD, of University of Oxford contributes FITC-Trehalose, Fluorescent Mycobacteria Probe.
• Anthony Janckila, PhD, of University of Louisville contributes Anti-Tartrate Resistant Acid Phosphatase (TRAP/ACP5) Antibodies.
• H. Teresa Ku, PhD, of City of Hope contributes Pancreatic Cell Differentiation Medium.
• Algirdas J. Jesaitis, PhD, of Montana State University contributes NOX/gp91phox, p22phox, and CAP-18 antibodies.
• Leslie B. Poole, PhD, and S. Bruce King, PhD, of Wake Forest University contributes DCP-Rho1, DCP-Alkyne, Biotinylated-Trx Loading Control Protein.
• Gerardo R. Vasta, PhD, of University of Maryland, Baltimore contributes GFP expressing Perkinsus marinus.
• University of Missouri - Columbia joins the Kerafast Community.

June 2014

• Case Western Reserve University joins the Kerafast Community.
• Thomas U. Schwartz, PhD, of Massachusetts Institute of Technology contributes LOBSTR E. coli Expression Strain.
• Amira Klip, PhD, of Hospital For Sick Children contributes L6 Rat Myoblast Cell Lines.
• Northwestern University joins the Kerafast Community.
• Michael W. W. Adams, PhD, of University of Georgia contributes Cytoplasmic [NiFe]-Hyrdogenase (SHI) and Ferredoxin [4Fe-4S].
• Michael P. Doyle, PhD, of University of Georgia contributes Yersinia pestis [6B5] Antibody and Hybridoma.
• The Ohio State University joins the Kerafast Community.
• Washington State University joins the Kerafast Community.
• Min-Hao Kuo, PhD, of Michigan State University contributes Hyperphosphorylated Microtubule-Associated Protein Tau (MAPT).
• Peter Kijun Kim, PhD, of Hospital for Sick Children contributes Pex2, Pex5, and PMP70 Antibodies.
• University of North Carolina at Wilmington joins the Kerafast Community.
• Stuart A. Aaronson, MD, of Icahn School of Medicine at Mount Sinai contributes LRP6 [1C10] Antibody.

May 2014

• XTAL Biostructures contributes Isocitrate Dehydrogenase 1 (IDH1) R132H and R132C variants.
• Cellomics Technology contributes Premade Lentiviruses.
• University of Nevada, Las Vegas joins the Kerafast Community.
• ArcticZymes contributes Heat Labile PCR Reagents.
• Press Release: Licensing Agreement Speeds Access to UGA Research Tools, Benefits Life Science Research.
• University of Arkansas, Division of Agriculture joins the Kerafast Community.
• Patricia Grasso, PhD, of Albany Medical College contributes Leptin-Related Synthetic Peptides and Antibody.
• Children's Hospital of Philadelphia joins the Kerafast Community.
• Iowa State University joins the Kerafast Community.

April 2014

• Cancer Institute of West Tennessee joins the Kerafast Community.
• University of Oklahoma joins the Kerafast Community.
• Charles A. Janeway, Jr., MD of Yale University contributes ICOS (CD278) [C398.4A] Antibody.
• R. Michael Garavito, PhD, of Michigan State University contributes DYKDDDDK (FLAG) Tag [2G11-C6-G9] Antibody.
• Joyce Rauch, PhD, of McGill University contributes Prothrombin [29J3-62] Antibody.
• Duncan C. Ferguson, VMD, PhD, of University of Georgia contributes TSH Beta (ovine/canine) [14H9.E4.A4] Antibody & Hybridoma.
• John Walker, PhD, of University of Missouri - St. Louis contributes Fluorinated Benzonitrile Compounds.

March 2014

• Michelle Letarte, PhD, of Hospital for Sick Children contributes Anti-Endoglin (CD105) [44G4] Antibody.
• Li Cai, PhD, of Rutgers University contributes CD44CR1-, Foxn4CR4.2-, and Notch1CR2-GFP Reporter Plasmids.
• Children’s Hospital Los Angeles joins the Kerafast Community.
• Alexei V. Demchenko, PhD and Michael R. Nichols, PhD, of University of Missouri - St. Louis, contribute Lipopolysaccharide Antagonist; AM-12.
• Alexander (Leggy) Arnold, PhD, of University of Wisconsin - Milwaukee contributes MSTI Fluorescence-Based Thiol-Reactive Assay.
• Albany Medical College joins the Kerafast Community.
• University of Louisville joins the Kerafast Community.
• Volkhard Lindner, MD, PhD, of Maine Medical Research Center Institute contributes CTHRC1, Collagen, pSMAD, VE Cadherin, ZO-2, and c-Myc Antibodies.
• Edward A. Dratz, PhD and Paul A. Grieco, PhD, of Montana State University, contribute Zwitterionic and pI Balancing Cy Dyes.

February 2014

• Aikaterini Kontrogianni-Konstantopoulos, PhD and Robert J. Bloch, PhD, of University Maryland, Baltimore contribute Anti-Obscurin Ig Domain 1 [5H10] Antibody.
• Connie L. Cepko, PhD, of Harvard University contributes GFP-Dependent Transcription System Plasmids.
• Stephen H. Leppla, PhD, of National Institutes of Health/NIAID contributes DNA-RNA Hybrid [S9.6] Antibody.
• The Scripps Research Institute contributes tdTomato [16D7] Antibody.
• Michigan State University joins the Kerafast Community.
• LSU Pennington Biomedical Research Center joins the Kerafast Community.
• John W. Kappler, PhD and Philippa Marrack, PhD, of National Jewish Health contribute Baculovirus E25 Protein, HIV-1 gp160, and SARS Spike Protein Antibodies.
• Hospital for Sick Children joins the Kerafast Community.
• Stormy J. Chamberlain, PhD and Marc Lalande, PhD, of University of Connecticut contribute Angelman Syndrome and Prader-Willi human induced pluripotent stem cells.

January 2014

• Montana State University joins the Kerafast Community.
• Western Australian Neuroscience Research Institute contributes Neuro-Dissociate Medium.
• David Thorley-Lawson, PhD, of Tufts University contributes EBV Latent Membrane Protein 1 [S12] Antibody.
• Cancer Research Technology contributes MultiDsk Ubiquitin Binding Protein Reagent.
• Michelle Momany, PhD, of University of Georgia contributes Aspergillus fumigatus Cell Wall Hybridomas.
• National Jewish Health joins the Kerafast Community.
• Carl P. Blobel, MD, PhD, of Hospital for Special Surgery contributes ADAM and SNX9 Antibodies.
• Cancer Research Technology contributes Quinol 2 Thioredoxin Reductase Inhibitor.
• Wright State University joins the Kerafast Community.

December 2013

• University of Connecticut joins the Kerafast Community.
• Louisiana State University joins the Kerafast Community.
• Baylor College of Medicine joins the Kerafast Community.
• Richard B. Meagher, PhD, of University of Georgia contributes various Actin and Profilin Antibodies.
• Brown University joins the Kerafast Community.
• University of Wisconsin - Milwaukee joins the Kerafast Community.
• McMaster University joins the Kerafast Community.
• Western Australian Neuroscience Research Institute joins the Kerafast Community.
• Brian D. Brown, PhD, of Icahn School of Medicine at Mount Sinai contributes microRNA Sensor and Decoy Libraries.
• Cancer Research Technology contributes suite of Immuno-Oncology Antibodies.
• National Institutes of Health/NIAID joins the Kerafast Community.
• University of Maryland, Baltimore joins the Kerafast Community.
• New York University joins the Kerafast Community.

November 2013

• Jean Brenchley, PhD, of Penn State University contributes pSVJ21 Psychrophilic Bacterium Shuttle Vector.
• Mark Howart, PhD, of University of Oxford contributes Traptavidin Protein.
• William T. Lee, PhD, of Health Research Incorporated contributes Bat Ig Light Chain [BT1-4F10] Hybridoma.
• University of Missouri - St. Louis joins the Kerafast Community
• David A. Fox, MD, of University of Michigan contributes CD60 and Von Willebrand Factor Antibodies.
• Health Research Incorporated joins the Kerafast Community.
• Mary Rusckowski, PhD, of University of Massachusetts Medical School contributes S-Acetyl-MAG3-NHS Ester Bi-functional Chelator.
• University of Oxford joins the Kerafast Community.
• University of Utah joins the Kerafast Community.

October 2013

• Alexander M. Zagariya, PhD, of University of Illinois at Chicago contributes Anti-Antiotensin II Antibodies.
• Elizaveta Benevolenskaya, PhD, of University of Illinois at Chicago contributes Anti-JARID1B [4440] Antibody.
• University of Michigan joins the Kerafast Community.
• University of Oregon joins the Kerafast Community.
• David T. Denhardt, PhD, of Rutgers University contributes Anti-Osteopontin Antibodies.
• Schepens Eye Research Institute joins the Kerafast Community.
• Andrew D. Hollenbach, PhD, of Louisiana State University Health Sciences Center contributes Anti-phospho Pax3, Ser201 [6A4E9] Antibody.
• Louisiana State University Health Sciences Center joins the Kerafast Community.
• University of Illinois at Chicago contributes LIN-9/BARA Antibodies.
• University of Georgia joins the Kerafast Community.
• Yale University joins the Kerafast Community.
• Duke University joins the Kerafast Community.

September 2013

• Andrew R. Kelleher, of Penn State College of Medicine explains the usefulness of the Anti-Puromycin [3RH11] Monoclonal Antibody for his thesis research looking at skeletal muscle disuse atrophy in the Kerafast Blog.
• University of North Carolina at Chapel Hill joins the Kerafast Community.
• Hospital for Special Surgery joins the Kerafast Community.
• Thomas N. Seyfried, PhD, of Boston College contributes Metastatic Tumor Cell Lines.
• Sheldon Park, PhD, of University at Buffalo contributes pRSET-mSA2 Protein Expression Vector for Engineered Monomeric Steptavidin 2 (mSA2) Protein.

August 2013

• Sheldon Park, PhD, of University at Buffalo explains the usefulness of the newly avaliable Monomeric Streptavidin Protein (mSA2) in the Kerafast Blog.
• Hao Chen, PhD, of University of Tennessee contributes Button Tether for Rat Infusion Studies.
• The University of Delaware joins the Kerafast Community.
• Lawrence Pfeffer, PhD, of University of Tennessee contributes STAT3 Dominant Negative (Y705F) Lentivirus.
• Boston College joins the Kerafast Community.

July 2013

• Columbia University joins the Kerafast Community.
• Gail M. Seigel, PhD, of University of Rochester explains the usefulness of the newly avaliable Retinal Cell Cytospins in the Kerafast Blog.
• Sheldon Park, PhD, of University at Buffalo contributes Engineered Monomeric Steptavidin 2 (mSA2) Protein.
• Dongfeng Pan, PhD, of University of Virginia publishes on further work describing the Neutrophil Specific, NIR Fluorescent Imaging Agent in Molecular Imaging, 2012 Sep-Oct;11(5):372-82.
• Te-Chung Lee, PhD, of University at Buffalo contributes Yin-Yang 1, Serum Response Factor, Epidermal Growth Factor, Fibroblast Growth Factor 2, Growth Hormone, VEGF, GST, and Myosin Heavy Chain Proteins and Antibodies.
• Click Chemistry Tools contributes new Trans-Cyclooctene (TCO)-Tetrazine bioconjugation reagents.
• Gail M. Seigel, PhD of University of Rochester contributes Retinal Cell Line (R28 and E1A-NR.3) Cytospins.

June 2013

• University at Buffalo joins the Kerafast Community.
• Thomas M. Moran, PhD, of Icahn School of Medicine at Mount Sinai contributes Influenza A Matrix Protein (E10) and Nucleoprotein (HT103) Antibodies.
• Kerafast customer publishes work on Burkholderia Infection using the Neutrophil Specific, NIR Fluorescent Imaging Agent available in the Kerafast Community.
• Lakshmi A. Devi, PhD, of Icahn School of Medicine at Mount Sinai contributes Activation State-Sensitive Opioid Receptor Antibodies.
• Nagoya University contributes Human Ovarian Yolk Sac Tumor Cell Line NOY1.

May 2013

• Thomas Hollis, PhD, of Wake Forest University explains how he came to develop a specialized Protein Nucleic Acid Crystal Screen in the KeraFAST Blog.
• New Mexico State University joins The Investigator's Annexe.
• Yuntao Wu, PhD, of George Mason University contributes Diphtheria Toxin Resistant HEK293T Cell Line 5H7.
• Sang Y. Lee, PhD, of Penn State College of Medicine contributes Stable SH-SY5Y HFE Expressing Cell Lines.

April 2013

• Kiyosumi Shibata, PhD, of Nagoya University contributes Human Plectin, domain-specific mAbs.
• James J. Chambers, PhD of University of Massachusetts Amherst contributes AMPA Receptor - Live Neuron Cell Fluorescent Probe.

March 2013

• Chunlei Su, PhD, DVM of University of Tennessee Knoxville contributes Toxoplasma gondi Whole Cell Antigen.
• University of Massachusetts Amherst joins The Investigator’s Annexe.
• Jack E. Bodwell, PhD of Dartmouth College contributes Anti-Glucocorticoid Receptor (FIGR) Monoclonal Antibody.

February 2013

• Gregory G. Tall, PhD of University of Rochester contributes Resistance to Inhibitors of Cholinesterase 8 (Ric-8) homologs.
• Nagoya University joins The Investigator’s Annexe.
• Laurie L. Parker, PhD of Purdue University contributes Photocleavable Alpha-Factor for Yeast.
• Dartmouth College joins The Investigator’s Annexe.
• Adolfo Garcia-Sastre, PhD of Mount Sinai School of Medicine contributes Anti-Human IRF3 Monoclonal Antibody.
• Gregory G. Tall, PhD of University of Rochester contributes G Protein beta 1 gamma 2 (β1γ2) heterodimer.
• Cellomics Technology contributes additional Premade Lentiviral Particles.

January 2013

• Click Chemistry Tools contributes additional Fluorescent Dyes and Click Chemistry Reagents.
• Aphios Corp. brings Natural Medicinal Chemistry Compounds.
• James H. Morrissey, PhD of University of Illinois at Urbana-Champaign contributes Polyphosphate, High MW (P700).
• The Genomics, Analytics and Proteomics Core (GAPC) at University of New England contributes Genomics and Mass Spectrometry Workshops as well as Genomics, Analytics, and Proteomics Services.
• University of Illinois at Urbana-Champaign joins The Investigator’s Annexe.
• Philip M. Carpenter, MD of University of California at Irvine contributes Human Laminin 332.
• Recombinant Human Insulin contributed to KeraFAST.
• Randal A. Skidgel, PhD of University of Illinois at Chicago contributes Human Carboxypeptidase D (CPD) Polyclonal Antibdies.

December 2012

• Tufts University joins The Investigator’s Annexe.
• Salk Institute joins The Investigator’s Annexe.
• University of New England joins The Investigator’s Annexe.
• Zibo Li, PhD of University of Southern California contribute Bifunctional Imaging Probes.
• John C. Chrivia, PhD of St. Louis University contributes p400 and SRCAP Polyclonal Antibodies.
• Jiing-Kuan Yee, PhD of City of Hope contributes Human Renal Proximal Tubule Epithelial (TH1) Cell Line.
• University of Pennsylvania joins The Investigator’s Annexe.
• Hua-Chen Chang, PhD of Indiana University contributes Lunasin, Natural Killer (NK) Cell Activating Peptide.
• Enrico Di Cera, MD of St. Louis University contributes Recombinant Human Wild-type and Inactive Alpha Thrombin variants.
• Steven L. Gonias, MD, PhD of University of Virginia contributes Human specific Cytokeratin 8 Monoclonal Antibody.
• University of Virginia contributes LacI Monoclonal Antibody.
• Jian Ping, PhD of Wayne State University contributes Ready-to-use and Load PCR Master Mix.
• University of North Carolina at Greensboro. joins The Investigator’s Annexe.
• Keith Reimann, DVM of Beth Israel Deaconess Medical Center contributes Marmoset IgG Monoclonal Antibodies.
• Geula Gibori, PhD of University of Illinois at Chicago contributes Hydroxysteroid Dehydrogenase Polyclonal Antibodies.
• Xiaoping Du, MD, PhD of University of Illinois at Chicago contributes Phospho-Integrin B3 Subunit Polyclonal Antibody.

November 2012

• Jay D. Potts, PhD of University of South Carolina School of Medicine contributes Microplate Loading Platform.
• University of Virginia contributes Anti-Human Salivary Amylase Monoclonal Antibody.
• Mary Jo LaDu, PhD of University of Chicago at Illinois contributes Anti-Amyloid Beta Peptide Monoclonal Antibody.
• Donald W. Kufe, MD of Dana-Farber Cancer Institute contributes Anti-MUC1 Monoclonal Antibodies.
• Jaideep Kapur, MD, PhD of University of Virginia contributes Anti-GABA-A Receptor Gamma 2 Subunit (10F10-C1-B8) Monoclonal Antibody.
• Joel Hockensmith, PhD of University of Virginia contributes Universal Anti-ATPaseA / SMARCAL1 (5A12-A7-A3) Monoclonal Antibody.
• St. Louis University joins The Investigator’s Annexe.
• Chad Borges, PhD of Arizona State University contributes Protein Buffers for Mass Spectrometric Immunoassay (MSIA).
• University of California-Irvine joins The Investigator’s Annexe.

October 2012

• W. Todd Lowther, PhD of Wake Forest School of Medicine contributes Free Methionine-(R)-Sulfoxide Reductase (fRMsr) variant.
• City of Hope joins The Investigator’s Annexe.
• Erik I. Hewett, MD of University of Virginia contributes Adenylate Cyclase Toxin Antibodies.
• University of Virginia contributes Human Serum Albumin Antibody.
• University of Southern California joins The Investigator’s Annexe.
• Bryce M. Paschal, PhD of University of Virginia contributes NTF2 Antibodies.
• Lester I. Binder, PhD of University of Virginia contributes Tau1 Antibody.
• University of South Carolina joins The Investigator’s Annexe
• National University of Singapore joins The Investigator’s Annexe

September 2012

• Jyothi Arikkath, PhD of University of Nebraska Medical Center contributes Primary Neuron Cells and Novel Freeze Medium.
• Click Chemistry Tools brings Fluorescent Dyes and Click Chemistry Reagents.
• Andrei Khokhlatchevz, PhD of University of Virginia contributes NORE1 Antibodies.
• John C. Herr, PhD of University of Virginia contributes CD52 Antibody.
• Roger A. Johns, MD, PhD of University of Virginia contributes Nitric Oxide Synthase.
• Shu-Man Fu, MD, PhD of University of Virginia contributes B Cell Antibodies.
• Gail M. Seigel, PhD of University of Rochester contributes Immortalized Retinal Cell Lines.

August 2012

• Kate Carroll, PhD of The Scripps Research Institute contributes Protein Tyrosine Phosphatase (PTP) Oxidation Probes.
• Arizona State University joins The Investigator’s Annexe.
• Ronald P. Taylor, PhD of University of Virginia contributes Complement System Monoclonal Antibodies.
• Anthony Frankfurter, PhD and Anthony Spano, PhD of University of Virginia contribute Microtubule-Associated Protein (MAP) and additional Tubulin, Isotype-Specific Monoclonal Antibodies.
• Celine DerMardirossian, PhD of The Scripps Research Institute contributes a polyclonal antibody recognizing PAK-1 and PAK-2.
• Lumiprobe brings Fluorescent Dyes and Click Chemistry Reagents.
• Christopher S. Francklyn, PhD of University of Vermont contributes Histidyl-tRNA Synthetase Proteins and Plasmids.
• David Cortez, PhD of Vanderbilt University Medical Center contributes Anti-phospho ATR (T1989) monoclonal antibody.

July 2012

• Vanderbilt University joins The Investigator’s Annexe.
• The Scripps Research Institute joins The Investigator’s Annexe.
• Cristina M. Furdui, PhD of Wake Forest University contributes Alkyne β-ketoester and Biotin-1,3-cyclopentanedione, new protein cysteine oxidation probes for studying cysteine sulfenic acid formation.
• Goutham Narla, MD, PhD of Mount Sinai School of Medicine contributes Anti-KLF6 Monoclonal Antibodies.
• Yiannis Ioannou, PhD of Mount Sinai School of Medicine contributes Anti-NPC1 Monoclonal Antibody.
• Adolfo Garcia-Sastre, PhD of Mount Sinai School of Medicine contributes Anti-RIG-I Monoclonal Antibody.
• Mount Siani School of Medicine contributes Anti RNF5 Monoclonal Antibody.

June 2012

• Denise C. Hocking, PhD of University of Rochester Medical Center contributes Recombinant Fibronectin and Vitronectin Variants
• Brian F. Volkman, PhD of Medical College of Wisconsin contributes Recombinant Human Chemokines.
• Dana Farber Cancer Research Institute joins The Investigator’s Annexe.
• Mount Sinai School of Medicine joins The Investigator’s Annexe.
• Scot R. Kimball, PhD, Penn State College of Medicine contributes Anti-Puromycin Antibody and Translation Initiation Factor Antibodies.

May 2012

• Anne B. Mason, PhD of University of Vermont contributes Soluble Transferrin Receptor.
• University of Chicago contributes monoclonal antibodies for Ovalbumin, Major Histocompatability Complex (MHC) variants, and Inosine-5'-monophosphate (IMP) Dehydrogenase
• Pavel A. Petukhov, PhD of UIC contributes Photoreactive HDAC Inhibitors.
• Anthony Frankfurter, PhD and Anthony Spano, PhD of University of Virginia contribute Anti-Class VI Beta Tubulin (AA16) Monoclonal Antibody.
• Lawrence Pfeffer, PhD of University of Tennessee contributes an Antisense miR-21 Lentivirus and Recombinant p65-GST Protein.

April 2012

• Glenn R. Gaudette, Ph.D. and George D. Pins, Ph.D. of Worcester Polytechnic Institute contribute Fibrin Microthread for Stem Cell Delivery.
• Michael A. Whitt, Ph.D. of University of Tennessee contributes Recombinant Vesicular Stomatitis Virus ΔG System.

March 2012

• Shu-Chan Hsu, Ph.D. of Rutgers University contributes Exocyst Antibodies.
• Shigeko Yamashiro, Ph.D. and Fumio Matsumura, Ph.D. of Rutgers University contribute Fascin-1 monoclonal antibody.
• Yaowu Hao, Ph.D of University of Texas-Arlington contributes Hollow Gold Nanoparticles.
• Florida State University contributes Recombinant Fibroblast Growth Factors and Kallikrein-Related Peptidase.
• KeraFast Closes on Series A Financing with FCA Venture Partnersto Scale its Unique Marketplace for Life Science Research Products.
• Purdue University, University of Vermont, Woods Hole Oceanographic Institute, Worcester Polytechnic Institute, and Medical College of Wisconsin join The Investigator’s Annexe.

February 2012

• Dr. Kenneth H. Roux of Florida State University adds Human IgE Protein.
• SUNY-Upstate joins The Investigator’s Annexe.
• ViraQuest, Inc brings premade adenovirus vectors.
• Dr. Gregory G. Tall of University of Rochester adds G Protein Subunits.

January 2012

• Eptiope Biotech, Inc brings monoclonal antibodies for specific tag and loading control epitopes.

December 2011

• Dr. Clifford J. Rosen of Maine Medical Center Research Institute adds Bone Immunoassay services.
• East Carolina University joins The Investigator’s Annexe.
• Cellomics Technology brings premade lentivirus particles for stable transduction and generation of iPS cells.
• Children's Hospital Boston joins The Investigator’s Annexe.
• Dr. Choogon Lee of Florida State University brings Circadian Clock Regulator Antibodies
• Dr. Yuntao Wu of George Mason University brings Rev-Dependent HIV Indicator T-Cell Line.
• Maine Manufacturing brings the gold standard protein microarray platform and FAST® Slides.

November 2011

• Dr. Daniel Cox of George Mason University brings a Tissue Mounting Membrane for increased tissue retention during histology processing.
• Dr. Philip Keehn, Brandeis University, adds a broad portfolio of unique chemical compounds.
• Cancer Research Technology (CRT) contributes monoclonal antibodies for oncology and epigenetics research. CRT is the cancer-focused technology development and commercialization arm of Cancer Research UK.
• Dr. Leslie B. Poole of Wake Forest University contributes Protein Cysteine Oxidation Probes for studying cysteine sulfenic acid formation.
• McGill University joins The Investigator’s Annexe.
• CalAsia Pharmaceuticals brings a range of recombinant human and rodent proteins to the KFP, KeraFAST Partner program.

October 2011

• George Mason University joins The Investigator’s Annexe.
• Dr. Keith Reimann, Beth Israel Deaconess Medical Center, brings anti-macaque and anti-human IgGs.

September 2011

• Florida State University joins The Investigator’s Annexe.
• Xtal Biostructures contributes recombinant human histones to the KFP, KeraFAST Partner program.
• Brighter Ideas, Inc brings Green Fluorescent Protein reagents to the KFP, KeraFAST Partner program.

August 2011

• Dr. Kenan Murphy of University of Massachusetts Medical School contributes Recominbeering Plasmids for Gene Replacement in Bacteria.
• Dr. Bruce King, Wake Forest University, adds Nitroxyl (HNO) donors and detectors.
• Dr. Lawrence Pfeffer of the University of Tennessee contributes STAT2-Defective Daudi Cells.
• SBH Sciences brings unique Recombinant Cytokines, Anti-Cytokine Monoclonal Antibodies and Laboratory Services to the KFP, KeraFAST Partner program.

July 2011

• Dr. Dongfeng Pan of the University of Virginia contributes a Neutrophil-Specific, NIR Fluorescent Imaging Agent.
• Dr. Ian Macara of the University of Virginia adds a monoclonal antibody.
• Dr. Tom Hollis, Wake Forest University, brings the Protein/Nucleic Acid Crystal Screen.

June 2011

• Monoclonal antibodies to Caspases and other Cell Death Pathway proteins were contributed by Harvard University.
• Dr. Roger Jones of Rutgers University contributes Cyclic-di-GMP.

May 2011

• Monoclonal antibodies to transcription factor E2F contributed by a major Cambridge, MA university.

April 2011

• Pressure Biosciences, Inc. adds PSI Shredder sample prep technology to the KFP, KeraFAST Partner Program.

March 2011

• Stratec Molecular adds a full line of DNA/RNA prep kits to KFP, the KeraFAST Partner Program.

January 2011

• Dr. Paul Leavis from Boston Biomedical Research Institute, adds unique peptides and derivatives.